Showing results (311-320 of 348) with videos related to

Sort By:
Pageof 35
Journal of Clinical Medicine|October 16, 2024
Factors beyond Body Mass Index Associated with Cardiometabolic Risk among Children with Severe ObesityEwa Kostrzeba, Mirosław Bik-Multanowski, Stephanie Brandt, et al.
Hormone Research|May 2, 2009
Network of European studies of genes in growth (NESTEGG)Linda B Johnston, Wiestske Ester, Janina Caliebe, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome)M O Savage, W F Blum, M B Ranke, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2008
Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassaysMichael P Brugts, Michael B Ranke, Leo J Hofland, et al.
Human Reproduction (Oxford, England)|February 8, 2005
Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001Helmuth G Doerr, Markus Bettendorf, Berthold P Hauffa, et al.
European Journal of Pediatrics|June 14, 2024
The age of the obesity onset is a very important factor for the development of metabolic complications and cardiovascular risk in children and adolescents with severe obesityEwa Szczudlik, Anna Stępniewska, Mirosław Bik-Multanowski, et al.
Hormone Research in Paediatrics|May 11, 2012
IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature)Janina Caliebe, Sander Broekman, Merel Boogaard, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized malesM W Elmlinger, I Mayer, D Schnabel, et al.
Pediatric Research|January 11, 2007
Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGSMichael B Ranke, Anders Lindberg, Angel Ferrández Longás, et al.
European Journal of Endocrinology|March 12, 2004
Central reassessment of GH concentrations measured at local treatment centers in children with impaired growth: consequences for patient managementBerthold P Hauffa, Nils Lehmann, Markus Bettendorf, et al.
Pageof 35